Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis

Company Overview

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

Key Stats

• Today's Range: $4.27 to $4.27
• 50-Day Range: $4.27 to $4.27
• 52-Week Range: $0.78 to $4.40
• Volume: N/A
• Average Volume: 1.99 million shs
• Market Capitalization: $891.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CVRS Stock Analysis - Frequently Asked Questions

How have CVRS shares performed this year?

Corindus Vascular Robotics' stock was trading at $4.27 at the beginning of the year. Since then, CVRS shares have increased by 0.0% and is now trading at $4.27.
View the best growth stocks for 2025 here.

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The medical equipment provider had revenue of $1.67 million for the quarter, compared to the consensus estimate of $3 million.

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Corindus Vascular Robotics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Corindus Vascular Robotics investors own include Amarin (AMRN), TransEnterix (TRXDW), Micron Technology (MU), Advanced Micro Devices (AMD), NVIDIA (NVDA), Helios and Matheson Analytics (HMNY) and Meta Platforms (META).

Company Calendar

• Last Earnings: 8/07/2018
• Today: 6/24/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Medical Appliances & Equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NYSEAMERICAN:CVRS
• Previous Symbol: NYSEMKT:CVRS
• CIK: N/A
• Web: www.corindus.com
• Phone: +1-508-6533335
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 208,685,000
• Free Float: N/A
• Market Cap: $891.08 million
• Optionable: Not Optionable
• Beta: N/A